Autoantibodies targeting microRNA Processing Bodies (PB/GW bodies) have been described broadly in various autoimmune conditions and have been suggested as being potentially complementary biomarkers in PBC patients [28,29]; these include GW182, Ge-1 and Ago2 [28–31]. This evidence concerns the gene AGO2 and primary biliary cholangitis.